Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan
Authors:
Open Access
- 11 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 32 (7) , 1063-1068
Abstract
Oral cancer is the fourth common male cancer and causally associated with environmental carcinogens in Taiwan. The reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) has a significant effect on tumorigenesis by limiting angiogenesis and invasion of tumors through the extracellular matrix. RECK downregulation has been confirmed in many human cancers and associated with lymph node metastasis clinically. In the present hospital-based case-controlled study, the demographic, RECK genotype and clinicopathologic data from 341 male oral cancer patients and 415 cancer-free controls were investigated. We found that RECK rs10814325, rs16932912, rs11788747 or rs10972727 polymorphisms were not associated with oral cancer susceptibility. Among 488 smokers, RECK polymorphisms carriers with betel quid chewing have a 7.62-fold [95% confidence interval (CI), 2.96–19.64] to 25.33-fold (95% CI, 9.57–67.02) risk to have oral cancer compared with RECK wild-type carrier without betel quid chewing. Among 352 betel quid chewers, RECK polymorphisms carriers with smoking have a 6.68-fold (95% CI, 1.21–36.93) to 18.57-fold (95% CI, 3.80–90.80) risk to have oral cancer compared with those who carried wild-type without smoking. In 263 betel quid chewing oral cancer patients, RECK rs10814325 polymorphism have a 2.26-fold (95% CI, 1.19–4.29) risk to have neck lymph node metastasis compared with RECK wild-type carrier. These results support that gene–environment interactions between the RECK polymorphisms, smoking and betel quid may alter oral cancer susceptibility and metastasis.Keywords
This publication has 32 references indexed in Scilit:
- Decreased RECK Expression Indicating Proteolytic Imbalance in Prostate Cancer is Associated with Higher Tumor Aggressiveness and Risk of Prostate-Specific Antigen Relapse after Radical ProstatectomyEuropean Urology, 2007
- Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancerEuropean Journal of Cancer, 2006
- Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significanceCurrent Medical Science, 2005
- The Membrane-Anchored Matrix Metalloproteinase (MMP) Regulator RECK in Combination with MMP-9 Serves as an Informative Prognostic Indicator for Colorectal CancerClinical Cancer Research, 2004
- Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancerEuropean Journal of Cancer, 2004
- RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodelingCancer and Metastasis Reviews, 2003
- Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifsCancer, 2003
- The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and AngiogenesisCell, 2001
- Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECKProceedings of the National Academy of Sciences, 1998
- Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.Proceedings of the National Academy of Sciences, 1989